HEADER PROTEIN TRANSPORT/INHIBITOR 15-NOV-13 4NMS TITLE CFTR ASSOCIATED LIGAND (CAL)PDZ DOMAIN BOUND TO PEPTIDE ICAL36(FLB-K- TITLE 2 1) (ANSRWPTS[4-FLUOROBENZOIC-ACYL-K]I) COMPND MOL_ID: 1; COMPND 2 MOLECULE: GOLGI-ASSOCIATED PDZ AND COILED-COIL MOTIF-CONTAINING COMPND 3 PROTEIN; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: UNP RESIDUES 284-370; COMPND 6 SYNONYM: CFTR-ASSOCIATED LIGAND, FUSED IN GLIOBLASTOMA, PDZ PROTEIN COMPND 7 INTERACTING SPECIFICALLY WITH TC10, PIST; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ICAL36(FLB-K-1) PEPTIDE; COMPND 11 CHAIN: C, D; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GOPC, CAL, FIG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET16B; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: PEPTIDE SYNTHESIS KEYWDS CAL, PIST, GOPC, FIG, CFTR, PDZ, PDZ-PEPTIDE, PROTEIN TRANSPORT- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.F.AMACHER,D.R.MADDEN REVDAT 3 13-MAR-24 4NMS 1 COMPND SOURCE REVDAT 2 20-SEP-23 4NMS 1 REMARK LINK REVDAT 1 01-OCT-14 4NMS 0 JRNL AUTH J.F.AMACHER,R.ZHAO,M.R.SPALLER,D.R.MADDEN JRNL TITL CHEMICALLY MODIFIED PEPTIDE SCAFFOLDS TARGET THE JRNL TITL 2 CFTR-ASSOCIATED LIGAND PDZ DOMAIN. JRNL REF PLOS ONE V. 9 03650 2014 JRNL REFN ESSN 1932-6203 JRNL PMID 25136860 JRNL DOI 10.1371/JOURNAL.PONE.0103650 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 980 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.5381 - 3.2477 1.00 2780 147 0.1747 0.1953 REMARK 3 2 3.2477 - 2.5797 1.00 2640 147 0.1658 0.2023 REMARK 3 3 2.5797 - 2.2542 1.00 2614 147 0.1744 0.1912 REMARK 3 4 2.2542 - 2.0483 1.00 2587 147 0.1567 0.1918 REMARK 3 5 2.0483 - 1.9016 1.00 2620 98 0.1538 0.2334 REMARK 3 6 1.9016 - 1.7896 1.00 2573 147 0.1874 0.2412 REMARK 3 7 1.7896 - 1.7000 1.00 2551 147 0.2232 0.2662 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.41 REMARK 3 B_SOL : 33.72 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.62400 REMARK 3 B22 (A**2) : -0.86790 REMARK 3 B33 (A**2) : -0.75620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1502 REMARK 3 ANGLE : 1.100 2027 REMARK 3 CHIRALITY : 0.074 230 REMARK 3 PLANARITY : 0.005 260 REMARK 3 DIHEDRAL : 15.250 558 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4NMS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1000083398. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-OCT-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8856 REMARK 200 MONOCHROMATOR : S1 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19346 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 19.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 16.330 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08900 REMARK 200 FOR THE DATA SET : 16.3300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 60.0000 REMARK 200 FOR SHELL : 3.460 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 4E34 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 33% (W/V) POLYETHYLENE GLYCOL, 0.2 M REMARK 280 SODIUM CHLORIDE, 0.1 M TRIS(HYDROXYMETHYL)AMINOMETHANE, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.13750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.88800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.86800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.88800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.13750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.86800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ICAL36(FLB-K-1) PEPTIDE IS OLIGOPEPTIDE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ICAL36(FLB-K-1) PEPTIDE REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA C 1 REMARK 465 ASN C 2 REMARK 465 SER C 3 REMARK 465 ARG C 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ICAL36(FLB-K-1) REMARK 800 PEPTIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF ICAL36(FLB-K-1) REMARK 800 PEPTIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4NMO RELATED DB: PDB REMARK 900 RELATED ID: 4NMP RELATED DB: PDB REMARK 900 RELATED ID: 4NMQ RELATED DB: PDB REMARK 900 RELATED ID: 4NMR RELATED DB: PDB REMARK 900 RELATED ID: 4NMT RELATED DB: PDB REMARK 900 RELATED ID: 4NMV RELATED DB: PDB DBREF 4NMS A 284 370 UNP Q9HD26 GOPC_HUMAN 284 370 DBREF 4NMS B 284 370 UNP Q9HD26 GOPC_HUMAN 284 370 DBREF 4NMS C 1 10 PDB 4NMS 4NMS 1 10 DBREF 4NMS D 1 10 PDB 4NMS 4NMS 1 10 SEQRES 1 A 87 GLY PRO ILE ARG LYS VAL LEU LEU LEU LYS GLU ASP HIS SEQRES 2 A 87 GLU GLY LEU GLY ILE SER ILE THR GLY GLY LYS GLU HIS SEQRES 3 A 87 GLY VAL PRO ILE LEU ILE SER GLU ILE HIS PRO GLY GLN SEQRES 4 A 87 PRO ALA ASP ARG CYS GLY GLY LEU HIS VAL GLY ASP ALA SEQRES 5 A 87 ILE LEU ALA VAL ASN GLY VAL ASN LEU ARG ASP THR LYS SEQRES 6 A 87 HIS LYS GLU ALA VAL THR ILE LEU SER GLN GLN ARG GLY SEQRES 7 A 87 GLU ILE GLU PHE GLU VAL VAL TYR VAL SEQRES 1 B 87 GLY PRO ILE ARG LYS VAL LEU LEU LEU LYS GLU ASP HIS SEQRES 2 B 87 GLU GLY LEU GLY ILE SER ILE THR GLY GLY LYS GLU HIS SEQRES 3 B 87 GLY VAL PRO ILE LEU ILE SER GLU ILE HIS PRO GLY GLN SEQRES 4 B 87 PRO ALA ASP ARG CYS GLY GLY LEU HIS VAL GLY ASP ALA SEQRES 5 B 87 ILE LEU ALA VAL ASN GLY VAL ASN LEU ARG ASP THR LYS SEQRES 6 B 87 HIS LYS GLU ALA VAL THR ILE LEU SER GLN GLN ARG GLY SEQRES 7 B 87 GLU ILE GLU PHE GLU VAL VAL TYR VAL SEQRES 1 C 10 ALA ASN SER ARG TRP PRO THR SER 2KK ILE SEQRES 1 D 10 ALA ASN SER ARG TRP PRO THR SER 2KK ILE MODRES 4NMS 2KK C 9 LYS N~6~-(4-FLUOROBENZOYL)-L-LYSINE MODRES 4NMS 2KK D 9 LYS N~6~-(4-FLUOROBENZOYL)-L-LYSINE HET 2KK C 9 18 HET 2KK D 9 18 HET GOL A 401 6 HET GOL A 402 6 HETNAM 2KK N~6~-(4-FLUOROBENZOYL)-L-LYSINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 2KK 2(C13 H17 F N2 O3) FORMUL 5 GOL 2(C3 H8 O3) FORMUL 7 HOH *181(H2 O) HELIX 1 1 LYS A 307 GLY A 310 5 4 HELIX 2 2 GLN A 322 GLY A 328 1 7 HELIX 3 3 LYS A 348 GLN A 359 1 12 HELIX 4 4 LYS B 307 GLY B 310 5 4 HELIX 5 5 GLN B 322 GLY B 328 1 7 HELIX 6 6 LYS B 348 GLN B 359 1 12 SHEET 1 A 4 ARG A 287 LEU A 292 0 SHEET 2 A 4 GLU A 362 TYR A 369 -1 O PHE A 365 N VAL A 289 SHEET 3 A 4 ASP A 334 VAL A 339 -1 N ALA A 335 O VAL A 368 SHEET 4 A 4 VAL A 342 ASN A 343 -1 O VAL A 342 N VAL A 339 SHEET 1 B 3 VAL A 311 ILE A 318 0 SHEET 2 B 3 ILE A 301 GLY A 306 -1 N THR A 304 O LEU A 314 SHEET 3 B 3 THR C 7 ILE C 10 -1 O ILE C 10 N ILE A 301 SHEET 1 C 4 ARG B 287 LYS B 293 0 SHEET 2 C 4 GLY B 361 VAL B 368 -1 O ILE B 363 N LEU B 291 SHEET 3 C 4 ALA B 335 VAL B 339 -1 N ALA B 335 O VAL B 368 SHEET 4 C 4 VAL B 342 ASN B 343 -1 O VAL B 342 N VAL B 339 SHEET 1 D 6 ARG B 287 LYS B 293 0 SHEET 2 D 6 GLY B 361 VAL B 368 -1 O ILE B 363 N LEU B 291 SHEET 3 D 6 ALA B 335 VAL B 339 -1 N ALA B 335 O VAL B 368 SHEET 4 D 6 VAL B 311 ILE B 318 -1 N ILE B 313 O ILE B 336 SHEET 5 D 6 ILE B 301 GLY B 306 -1 N SER B 302 O SER B 316 SHEET 6 D 6 SER D 8 ILE D 10 -1 O SER D 8 N ILE B 303 LINK C SER C 8 N 2KK C 9 1555 1555 1.33 LINK C 2KK C 9 N ILE C 10 1555 1555 1.33 LINK C SER D 8 N 2KK D 9 1555 1555 1.33 LINK C 2KK D 9 N ILE D 10 1555 1555 1.33 SITE 1 AC1 6 LEU A 292 LYS A 293 GLU A 294 LYS A 350 SITE 2 AC1 6 HOH A 515 HOH A 531 SITE 1 AC2 5 LYS A 348 GLU A 351 HOH A 550 HOH A 555 SITE 2 AC2 5 GLU B 364 SITE 1 AC3 27 GLY A 298 LEU A 299 GLY A 300 ILE A 301 SITE 2 AC3 27 SER A 302 ILE A 303 THR A 304 HIS A 309 SITE 3 AC3 27 VAL A 311 HIS A 349 LEU A 356 ILE B 286 SITE 4 AC3 27 PRO B 312 LEU B 337 ARG B 345 VAL B 368 SITE 5 AC3 27 HOH C 101 HOH C 102 HOH C 103 HOH C 105 SITE 6 AC3 27 HOH C 106 HOH C 108 HOH C 109 HOH C 110 SITE 7 AC3 27 HOH C 112 HOH C 113 HOH C 114 SITE 1 AC4 32 GLY A 284 PRO A 285 ILE A 286 ASP A 325 SITE 2 AC4 32 ARG A 345 VAL A 370 LEU B 292 GLY B 298 SITE 3 AC4 32 LEU B 299 GLY B 300 ILE B 301 SER B 302 SITE 4 AC4 32 ILE B 303 THR B 304 HIS B 309 VAL B 311 SITE 5 AC4 32 GLU B 317 HIS B 349 VAL B 353 ARG B 360 SITE 6 AC4 32 GLY B 361 GLU B 362 HOH B 421 HOH B 425 SITE 7 AC4 32 HOH B 450 HOH D 101 HOH D 102 HOH D 103 SITE 8 AC4 32 HOH D 105 HOH D 107 HOH D 108 HOH D 110 CRYST1 36.275 47.736 97.776 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027567 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020949 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010227 0.00000